Ali Gürel

938 total citations
35 papers, 557 citations indexed

About

Ali Gürel is a scholar working on Pathology and Forensic Medicine, Physiology and Surgery. According to data from OpenAlex, Ali Gürel has authored 35 papers receiving a total of 557 indexed citations (citations by other indexed papers that have themselves been cited), including 7 papers in Pathology and Forensic Medicine, 7 papers in Physiology and 5 papers in Surgery. Recurrent topics in Ali Gürel's work include Adipose Tissue and Metabolism (6 papers), Chemotherapy-induced organ toxicity mitigation (6 papers) and Inflammatory Biomarkers in Disease Prognosis (4 papers). Ali Gürel is often cited by papers focused on Adipose Tissue and Metabolism (6 papers), Chemotherapy-induced organ toxicity mitigation (6 papers) and Inflammatory Biomarkers in Disease Prognosis (4 papers). Ali Gürel collaborates with scholars based in Türkiye, United States and Kazakhstan. Ali Gürel's co-authors include Tuncay Kuloğlu, Suna Aydın, Ayhan Doğukan, İbrahim Şahin, Mehmet Kalaycı, Musa Yılmaz, Ramazan Ulu, Hüsnü Değirmenci, Levent Demirtaş and Bilge Aygen and has published in prestigious journals such as SHILAP Revista de lepidopterología, Peptides and Andrologia.

In The Last Decade

Ali Gürel

30 papers receiving 547 citations

Peers — A (Enhanced Table)

Peers by citation overlap · career bar shows stage (early→late) cites · hero ref

Name h Career Trend Papers Cites
Ali Gürel Türkiye 8 257 154 122 80 76 35 557
Jiangying Kuang China 15 248 1.0× 232 1.5× 184 1.5× 56 0.7× 73 1.0× 31 689
Eulalia Alonso‐Iglesias Spain 11 233 0.9× 191 1.2× 223 1.8× 31 0.4× 90 1.2× 12 764
Akihiro Honda Japan 14 161 0.6× 187 1.2× 172 1.4× 29 0.4× 171 2.3× 56 662
Madhusudanarao Vuda Switzerland 14 166 0.6× 290 1.9× 124 1.0× 35 0.4× 56 0.7× 18 642
Orhan Lepara Bosnia and Herzegovina 11 97 0.4× 117 0.8× 90 0.7× 35 0.4× 43 0.6× 68 541
Seok Man Son South Korea 15 243 0.9× 162 1.1× 189 1.5× 24 0.3× 89 1.2× 43 821
Xiang Hu China 15 212 0.8× 134 0.9× 166 1.4× 45 0.6× 39 0.5× 34 586
Rena Pollack Israel 13 103 0.4× 159 1.0× 142 1.2× 100 1.3× 57 0.8× 32 676
Haitao Xiao China 9 223 0.9× 253 1.6× 114 0.9× 33 0.4× 174 2.3× 25 722

Countries citing papers authored by Ali Gürel

Since Specialization
Citations

This map shows the geographic impact of Ali Gürel's research. It shows the number of citations coming from papers published by authors working in each country. You can also color the map by specialization and compare the number of citations received by Ali Gürel with the expected number of citations based on a country's size and research output (numbers larger than one mean the country cites Ali Gürel more than expected).

Fields of papers citing papers by Ali Gürel

Since Specialization
Physical SciencesHealth SciencesLife SciencesSocial Sciences

This network shows the impact of papers produced by Ali Gürel. Nodes represent research fields, and links connect fields that are likely to share authors. Colored nodes show fields that tend to cite the papers produced by Ali Gürel. The network helps show where Ali Gürel may publish in the future.

Co-authorship network of co-authors of Ali Gürel

This figure shows the co-authorship network connecting the top 25 collaborators of Ali Gürel. A scholar is included among the top collaborators of Ali Gürel based on the total number of citations received by their joint publications. Widths of edges represent the number of papers authors have co-authored together. Node borders signify the number of papers an author published with Ali Gürel. Ali Gürel is excluded from the visualization to improve readability, since they are connected to all nodes in the network.

All Works

20 of 20 papers shown
2.
Gürel, Ali, et al.. (2021). Effects of N-acetylcysteine on kidney tissue, matrix metalloproteinase-2, irisin and oxidative stress in a diabetes mellitus model. Biotechnic & Histochemistry. 96(8). 616–622. 5 indexed citations
3.
Demır, Mustafa, Ali Gürel, Ayhan Doğukan, et al.. (2020). Associations of platelet indices with proteinuria and chronic kidney disease. Journal of International Medical Research. 48(6). 1220717626–1220717626. 5 indexed citations
4.
Gürel, Ali, et al.. (2020). Theraupeutic potency of benfotiamine against methotrexate-induced kidney injury and irisin immunoreactivity. SHILAP Revista de lepidopterología. 9(2). 244–253. 1 indexed citations
5.
Gürel, Ali, et al.. (2020). Neurogenic Bladder and Acute Kidney Injury in Leukodystrophy. Cureus. 12(6). e8707–e8707. 2 indexed citations
6.
Doğantekin, Akif, et al.. (2018). Is there a relationship between serum vaspin levels and insulin resistance in chronic renal failure?. Pakistan Journal of Medical Sciences. 35(1). 230–235. 7 indexed citations
7.
Mertoğlu, Cuma, et al.. (2018). Ischemic modified albumin increases in acute kidney injury. Revista română de medicină de laborator. 26(1). 37–43. 5 indexed citations
8.
Kuzucuoğlu, Catherine, et al.. (2018). SON BUZUL MAKSİMUM (LGM)-GEÇ HOLOSEN EREGLI HAVZASININ PALEOÇEVRESEL EVRİMİ: JEOLOJİK İNDİKATÖRLER YARDIMIYLA İLK SONUÇLAR. Ömer Halisdemir Üniversitesi Mühendislik Bilimleri Dergisi. 1214–1219.
9.
Mertoğlu, Cuma, Murat Günay, Ali Gürel, & Mehmet Güngör. (2017). Myo-Inositol Oxygenase as a Novel Marker in the Diagnosis of Acute Kidney Injury. Journal of Medical Biochemistry. 37(1). 1–6. 18 indexed citations
10.
Ulu, Ramazan, Ayhan Doğukan, Ali Gürel, et al.. (2015). The renoprotective effect of curcumin in cisplatin-induced nephrotoxicity. Renal Failure. 37(2). 332–336. 96 indexed citations
11.
Gürel, Ali, et al.. (2015). Plasma and Saliva Irisin Levels of Patients with Diabetic Nephropathy and Non-Diabetic Proteinuria and Non-Diabetic Proteinuria. Turkish Nephrology Dialysis Transplantation. 24(3). 302–306. 2 indexed citations
12.
Gürel, Ali, et al.. (2015). Waardenburg Syndrome and nephrotic syndrome coexistence. DergiPark (Istanbul University). 1 indexed citations
13.
Demirtaş, Levent, et al.. (2015). Association of hematological indicies with diabetes, impaired glucose regulation and microvascular complications of diabetes.. PubMed. 8(7). 11420–7. 97 indexed citations
14.
Çeli̇ker, Hüseyin, Ayhan Doğukan, Nevin İlhan, et al.. (2014). Can serum NGAL levels be used as an inflammation marker on hemodialysis patients with permanent catheter?. Renal Failure. 37(1). 77–82. 13 indexed citations
15.
Kuloğlu, Tuncay, Suna Aydın, Mehmet Eren, et al.. (2014). Irisin: A potentially candidate marker for myocardial infarction. Peptides. 55. 85–91. 102 indexed citations
16.
Aydın, Suna, Tuncay Kuloğlu, Mehmet Nesimi Eren, et al.. (2013). Cardiac, skeletal muscle and serum irisin responses to with or without water exercise in young and old male rats: Cardiac muscle produces more irisin than skeletal muscle. Peptides. 52. 68–73. 142 indexed citations
17.
Ulu, Ramazan, Ayhan Doğukan, Mehmet Tuzcu, et al.. (2013). Modulation of Nrf2/HO-1 by Thymoquinone During Cisplatin-Induced Nephrotoxicity. Turkish Nephrology Dialysis Transplantation. 22(2). 182–187. 5 indexed citations
18.
Özden, Mehmet, Ali Gürel, Ayşe Sağmak Tartar, Ramazan Ulu, & Ayhan Doğukan. (2012). Resistant Yersinia Enterocolitica Peritonitis in a Peritoneal Dialysis Patient. Turkish Nephrology Dialysis Transplantation. 21(3). 310–312. 1 indexed citations
19.
Gürel, Ali, et al.. (2011). İSTANBUL'UN EKOLOJİK YAPISI ÜZERİNE BİR ARAŞTIRMA. 1 indexed citations
20.
Gürel, Ali, et al.. (2011). Türkiye’nin dört farklı iklim bölgesinde ısıtma ve soğutma yükleri için optimum yalıtım kalınlıklarının belirlenmesi. DergiPark (Istanbul University). 2 indexed citations

Rankless uses publication and citation data sourced from OpenAlex, an open and comprehensive bibliographic database. While OpenAlex provides broad and valuable coverage of the global research landscape, it—like all bibliographic datasets—has inherent limitations. These include incomplete records, variations in author disambiguation, differences in journal indexing, and delays in data updates. As a result, some metrics and network relationships displayed in Rankless may not fully capture the entirety of a scholar's output or impact.

Explore authors with similar magnitude of impact

Rankless by CCL
2026